after yesterdays agm statement the share price has risen 50% how much upside is left or is this another false dawn?
http://www.alexa.com/data/details/traffic_details/thewellnessshop.co.uk
womans hour link below.
http://www.bbc.co.uk/radio4/womanshour/04/2008_08_mon.shtml

squidd ,

The same here, hold on to your fortune everyone.

Millions of people wordwide are taking GSK Seroxat antidepressant. But this morning it is revealed that the latest trials show it to produce suicidal tendencies.
Can't but help ULT.

http://news.bbc.co.uk/1/hi/health/4172482.stm

Full version of the news re GSK Seroxat at above link

rise today could be due to the itn discussing problems associated with Anti-depressants for the mental health. ULT method looking better all the time

Thought for tonight: Psychopaths build castles in the air, neurotics live in castles in the air, and ULT calls to collect the rent.

Excellent day today now bid price of 1.87p.
Should be a rush for the shares once again today.
Could easily see over 2p now.
The share of the moment?
Announcement as well could be tomorrow.
My advice is to watch this stock closely.
Then you wont need their product.

Beating the blues recommended in NICE's FAD

BOOM!

you lucky bastards!! well done!!

Thanks to Woodie for me, what do you reckon the best place to take half out, I'm up 500% at the mo! or should I just forget about these, as US is a bigger market

p+f projected target reached

I`ll give you the next risk/reward target when I can

well done. Nice to imagine all the smiley faces

Thanks snip

potentially 5.375 with a risk of 1.325 but important to remember that time does not come into it

Personally I would take half profits and let the rest run because there is nothing worse than seeing profits vanish

The Times today
One of Britain's most widely prescribed antidepressants, GLAXOSMITHKLINE's Seroxat, linked to a seven-fold increase in suicide attempts

old news revisited today !!!!

That's true, it was only a 1k investment, i may put in a s/l after we've gone over 4, here's hoping! thanks

rsi looks very overbought so I would expect a bit of a retracement soon

I don`t hold these but I am interested in TA and like to share

this is more than TA, its the rally to the expected FAD / NICE news thats supposed to be out either today or in the next few days according to other chapps on the DVFN board

NICE to see a rise today after the strong s/price over the last week,at the moment the s/price is overvalued.the last 6 months accounting period ended at end of july these results will be issued in dec,they will show a slight profit having said that the outlook over 2 years out is the reason why i still will not sell even though iam sitting on a nice paper profit at the moment.

got out this morning with a handsome 60% profit as I expect some downturn b4 formal report is handed over to NHS in Nov. Will be back for more though

23th August 2005

FINAL NICE DETERMINATION RECOMMENDS BEATING THE BLUES


In its Final Appraisal Determination published today, the National Institute for Clinical Excellence (NICE) has concluded that Beating the Blues, the flagship product of interactive healthcare specialists Ultrasis,
is the only Computerised Cognitive Behaviour Therapy (CCBT) program to be recommended for the treatment of mild to moderate depression within the NHS.

Tasked by the Department of Health and the National Assembly for Wales, NICE has conducted an appraisal of CCBT in order to provide recommendations regarding its suitability for the treatment of depression as part of the mainstream NHS provision. Following a thorough consultation during which the effectiveness of three CCBT packages were examined, the Institute has now published its final findings.

In line with the previously published preliminary Appraisal Consultation Documents, Beating the Blues has been singled out as the only evidence-based program recommended for use in the stepped care management of depression in primary and secondary care. The Final Appraisal Determination strongly recommends that all patients with mild and moderate depression are offered Beating the Blues through the NHS. The other two CCBT products for depression that were assessed can only be used in the context of clinical trials designed to generate data on their clinical effectiveness.

Mental health issues such as anxiety and depression has become increasingly common over the last decade causing considerable strain on the NHS, commented Dr Charlie Martin, Ultrasis healthcare and biotechnology expert. With the continuous scares about the safety of antidepressants, the need for a non invasive depression treatment offered on the NHS has never been greater.

Ultrasis CEO, Graham Lewis, said; We are delighted that the final recommendation from NICE has reaffirmed the Institutes previous assessments about the effectiveness and suitability of Beating the Blues. This is a major development which is set to open up unprecedented opportunities for Ultrasis within the NHS, once the recommendation is formally made to the Department of Health and the National Assembly for Wales.

With the Final Appraisal Determination now published, due process gives the manufacturers of all packages and other relevant organisations included in the consultation the right to appeal against the judgments of the Institute. Any such appeals will be considered in November this year and guidance made to the NHS becomes official thereafter.

The Final Appraisal Determination can be obtained through the NICE web site www.nice.org.uk